BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11550303)

  • 1. Treatment of oligodendroglioma: an update.
    Paleologos NA; Cairncross JG
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
    Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined surgery, radiation, and chemotherapy for oligodendroglial gliomatosis cerebri.
    Fukushima Y; Nakagawa H; Tamura M
    Br J Neurosurg; 2004 Jun; 18(3):306-10. PubMed ID: 15327240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendroglioma: clinical profile and treatment results.
    Jacob R; Jyothirmayi R; Dalal Y; Nambiar U; Rajan B; Nair MK
    Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic oligodendroglial tumors: a tale of two trials.
    Gilbert MR; Lang FF
    J Clin Oncol; 2006 Jun; 24(18):2689-90. PubMed ID: 16782906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment of glyal and metastatic tumors of the brain].
    Fadeev BP; Zhabina RM
    Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM
    Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
    Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic oligodendroglioma and oligoastrocytoma.
    van den Bent MJ
    Neurol Clin; 2007 Nov; 25(4):1089-109, ix-x. PubMed ID: 17964027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and neoadjuvant treatment for primary brain tumors in adults.
    Grossman SA; Norris LK
    Semin Oncol; 1995 Dec; 22(6):530-9. PubMed ID: 8539630
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
    Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High grade (B) oligodendroglioma. Concerns and pitfalls in the intraoperative examination of smears].
    Beuvon F; Varlet P; Fallet C; Trystram D; Daumas-Duport C
    Clin Exp Pathol; 1999; 47(6):286-96. PubMed ID: 10812434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrogliomas.
    Peterson K; Cairncross JG
    Neurol Clin; 1995 Nov; 13(4):861-73. PubMed ID: 8584001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade oligodendroglioma: current treatments and future hopes.
    Lwin Z; Gan HK; Mason WP
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1651-61. PubMed ID: 19895248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
    Walker C; du Plessis DG; Fildes D; Haylock B; Husband D; Jenkinson MD; Joyce KA; Broome J; Kopitski K; Prosser J; Smith T; Vinjamuri S; Warnke PC
    Clin Cancer Res; 2004 Nov; 10(21):7182-91. PubMed ID: 15534091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
    Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
    J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.